Takeda Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
141
- Portfolio
-
51
- Exits
-
53
Takeda Ventures General Information
Company Description
Founded in 2001, Takeda Ventures is a corporate venture capital arm of Takeda Pharmaceutical Company Limited based in Cambridge, Massachusetts. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. It seeks to invest in healthcare, life sciences, and oncology sectors in the United States, Western Europe, and Canada region.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 500 Kendall Street
- Cambridge, MA 02142
- United States
Takeda Ventures Investments (141)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Be Biopharma | 01-Oct-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
Accipiter Biosciences | 17-May-2024 | Biotechnology | Stealth | |||
Cerevance | 13-Mar-2024 | Drug Discovery | Clinical Trials - Phase 3 | |||
Harness Therapeutics | 01-Dec-2023 | Biotechnology | Product In Beta Test | |||
EvolveImmune Therapeutics | 16-Nov-2023 | Drug Discovery | Pre-Clinical Trials | |||
Larkspur Biosciences | 23-May-2023 | Drug Delivery | Startup | |||
Ensoma | 16-May-2023 | Drug Discovery | Clinical Trials - General | |||
OncoResponse | 01-May-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
Enzyre | 02-Nov-2022 | Later Stage VC | Diagnostic Equipment | Generating Revenue | ||
HC Bioscience | 01-Nov-2022 | Early Stage VC | Biotechnology | Pre-Clinical Trials |
Takeda Ventures Exits (53)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
ImmPACT Bio | 31-Oct-2024 | Merger/Acquisition | |
Chordia Therapeutics | 14-Jun-2024 | ||
Fimecs | 26-Mar-2024 | ||
ArtisanBio | 24-Jan-2024 | ||
Arix Bioscience | 22-Jan-2024 | ||
Prosetta Biosciences | 01-Sep-2023 | ||
Turnstone Biologics | 24-Jul-2023 | ||
StrideBio | 05-Apr-2023 | ||
Noile-Immune Biotech | 29-Mar-2023 | IPO | |
Ambys Medicines | 23-Feb-2023 | Merger/Acquisition |
Takeda Ventures Investments by Industry, Year, and Region
Takeda Ventures Co-Investors (206)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
OrbiMed | 6 | ||||
Alexandria Venture Investments | |||||
Bristol-Myers Squibb | |||||
Johnson & Johnson Innovation - JJDC | |||||
SV Health Investors |
Takeda Ventures FAQs
-
What is Takeda Ventures?
Founded in 2001, Takeda Ventures is a corporate venture capital arm of Takeda Pharmaceutical Company Limited based in Cambridge, Massachusetts.
-
When was Takeda Ventures founded?
Takeda Ventures was founded in 2001.
-
Where is Takeda Ventures headquartered?
Takeda Ventures is headquartered in Cambridge, MA.
-
How many investments has Takeda Ventures made?
Takeda Ventures has made 141 investments.
-
What has Takeda Ventures invested in?
Takeda Ventures has made numerous investments in companies like Be Biopharma, Accipiter Biosciences, and Cerevance within the Drug Discovery and Biotechnology industries.
-
What has Takeda Ventures invested in recently?
Takeda Ventures's latest investment was on 01-Oct-2024 in Be Biopharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »